Advanced search
Publication Cover
Modern Rheumatology Volume 22, 2012 - Issue 4
Journal homepage
87
Views
29
CrossRef citations to date
0
Altmetric
Original Article

High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome

Tomoki OriguchiDepartment of Rehabilitation Sciences, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8520, Japan;Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, JapanCorrespondence[email protected]
,
Kazuhiko ArimaDepartment of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Shin-ya KawashiriDepartment of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Mami TamaiDepartment of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Satoshi YamasakiDepartment of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Hideki NakamuraDepartment of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
,
Toshiaki TsukadaDepartment of Internal Medicine, Isahaya Health Insurance General Hospital, 24-1 Eishohigashi-machi,Isahaya 854-0071, Japan
,
Toshiyuki AramakiDepartment of Internal Medicine, Nagasaki Atomic Bomb Hospital, 3-15 Morimachi, Nagasaki 852-8511, Japan
,
Masako FuruyamaDepartment of Rheumatology, Nagasaki Kita Hospital, 800 Motomura-go, Togitsu-cho, Nishisonogi-gun 851-2103, Japan
,
Taiichiro MiyashitaDepartment of General Medicine, National Hospital Organization Nagasaki Medical Center, 2-1001-1 Kuhara, Omura 856-8562, Japan
,
Yojiro KawabeDepartment of Rheumatology, National Hospital Organization Ureshino Medical Center, 2436 Oaza Geshukuhei, Ureshino-cho, Ureshino 843-0393, Japan
,
Nozomi IwanagaDepartment of Rheumatology, Sasebo Chuo Hospital, 15 Yamato-cho, Sasebo 857-1195, Japan
,
Kaoru TeradaDepartment of Rheumatology, Sasebo Chuo Hospital, 15 Yamato-cho, Sasebo 857-1195, Japan
,
Yukitaka UekiDepartment of Rheumatology, Sasebo Chuo Hospital, 15 Yamato-cho, Sasebo 857-1195, Japan
,
Takaaki FukudaDepartment of Rheumatology, Kurume Medical Center, 155-1 Kokubu-machi, Kurume 839-0863, Japan
,
Katsumi EguchiDepartment of Internal Medicine, Sesebo Municipal Hospital, 9-3 Hirase-machi, Sasebo 857-8511, Japan
&
Atsushi KawakamiDepartment of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan
 show all
Pages 584-588 | Received 04 Aug 2011, Accepted 31 Oct 2011, Published online: 02 Jan 2014

References

  • McCarty DJ, O'Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. JAMA. 1985;254:2763–7.
  • Russell EB, Hunter JB, Pearson L, McCarty DJ. Remitting seronegative symmetrical synovitis with pitting edema. Thirteen additional cases. J Rheumatol. 1990;17:633–9.
  • Sibifia J, Friess S, Schaeverbeke T, Maloisel F, Bertin P, Goichot B, et al. Remitting seronegative synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? J Rheumatol. 1999;26:115–20.
  • Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M, et al. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis. 2005;64:1653–4.
  • Kawashiri S, Nakano M, Kawakami A, Eguchi K. Monitoring of therapeutic efficacy in a patient with RS3PE syndrome by sero-logic variables and radiographic methods. Rheumatol Int. 2010;30:1677–80.
  • Tune SE, Arshan C, Bayram N, Sahin M, Akkus S, Yorgancigil H. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome): a report of two cases and review of the literature. Rheumatol Int. 2004;24:234–7.
  • Yeh Y, Sheu B, Cheng H, Wang YL, Yang HB, Wu JJ. Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival. Dig Dis Sci. 2010;55:1649–57.
  • Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta. 1992;211:59–72.
  • Olive A, del Blanco J, Pons M, Vaquero M, Tena X. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. J Rheumatol. 1997;24:333–6.
  • Queiro R. RS3PE syndrome: a clinical and immunological study. Rheumatol Int. 2004;24:103–5.
  • Cantini F, Salvarani C, Olivieri I. Paraneoplastic remitting sero-negative symmetrical synovitis with pitting edema. Exp Rheu-matol. 1999;17:741–4.
  • Ribbens C, Martin y Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, et al. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis. 2002;61:161–6.
  • Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res. 2004;10:8229–34.
  • Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 2004;23:101–17.
  • Inuzuka K, Ogata Y, Nagase H, Shirouzu K. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colo-rectal carcinoma. J Surg Res. 2000;93:211–8.
  • Gohji K, Fujimoto N, Komiyama T, Fujii A, Ohkawa J, Ka-midono S, et al. Elevation of serum levels of matrix metallo-proteinase-2 and -3 as new predictors of recurrence in patients with urothefial carcinoma. Cancer. 1996;78: 2379–87.
  • Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, et al. Expression and tissue localization of membrane-types 1,2, and 3 matrix metalloproteinases in human invasive breast carci-nomas. Cancer Res. 1997;57:2055–60.
  • Kerkeld E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol. 2003;12:109–25.
  • Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D. Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum. 1999;29:43–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.